Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer

(MedPage Today) — Nearly three-quarters of patients with biochemically recurrent prostate cancer remained metastasis-free 5 years after salvage radiotherapy (sRT) informed by prostate-specific membrane antigen (PSMA) PET/CT, a retrospective…